Mesenchymal stem cell-derived exosomes can ease renal interstitial fibrosis by delivering the von Hippel-Lindau tumor suppressor protein (pVHL) into kidney cells, where it tags hypoxia-inducible factor-1α (HIF-1α) for destruction, according to a study published in BMC Biology.
Chronic kidney disease is a global health burden that frequently progresses to renal interstitial fibrosis, the scarring process that erodes kidney function. Mesenchymal stem cell-derived exosomes, membrane-bound vesicles released by stem cells, have previously shown therapeutic potential in kidney repair, but their role in hypoxia-driven fibrosis had remained undefined. The research team, led by Chen Qi, Bei Li, Wei Wu, Linru Shi, Xianbin Xia and Cheng Ji, set out to test whether exosomes from human umbilical cord mesenchymal stem cells (hucMSC-Ex) attenuate fibrosis by destabilizing HIF-1α.
In the experimental model, hypoxia combined with mechanical stress increased nuclear HIF-1α levels in tubules of kidneys subjected to unilateral ureteral obstruction (UUO) and triggered fibrosis.
Treatment with hucMSC-Ex markedly reduced renal collagen and α-SMA, two established markers of fibrotic tissue remodeling. The effect points to a measurable dampening of the scarring response in the obstructed kidneys.
The mechanistic explanation lies in the cargo of the vesicles. The hucMSC-Ex were enriched in pVHL, and after uptake they increased pVHL abundance in recipient renal cells, promoting ubiquitination of HIF-1α and marking the protein for proteasome-dependent degradation. By lowering HIF-1α levels even under hypoxic stress, the exosomes appear to interrupt the signaling that sustains fibrosis.
The authors conclude that hucMSC-Ex alleviate renal interstitial fibrosis by delivering pVHL to facilitate HIF-1α ubiquitination and degradation, offering what they describe as a cell-free anti-fibrotic strategy.
Subject of Research: Stem cell-derived exosomes as a cell-free approach to renal interstitial fibrosis via pVHL-mediated HIF-1α degradation
Article Title: Mesenchymal stem cell-derived exosomes alleviate renal interstitial fibrosis via pVHL-mediated HIF-1α ubiquitination and degradation
Article References: Qi, C., Li, B., Wu, W., Shi, L., Xia, X., & Ji, C. (2026). Mesenchymal stem cell-derived exosomes alleviate renal interstitial fibrosis via pVHL-mediated HIF-1α ubiquitination and degradation. BMC Biology. https://doi.org/10.1186/s12915-026-02766-6
Image Credits: AI Generated
DOI: 10.1186/s12915-026-02766-6
Keywords: mesenchymal stem cells, exosomes, renal fibrosis, chronic kidney disease, HIF-1α, pVHL, ubiquitination, proteasomal degradation, hypoxia, UUO model, human umbilical cord, cell-free therapy
News Source: Drew Townsend. (October 28, 2026). Stem Cell Exosomes Deliver pVHL to Degrade HIF-1α and Ease Kidney Scarring. Scienmag.
